Contagious and other aspects of nocardiosis in the compromised host.
D000293:Adolescent; D000328:Adult; D000391:Air Microbiology; D000741:Anemia, Aplastic / Q000139:chemically induced; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D005260:Female; D006469:Hemoptysis / Q000209:etiology; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000139:chemically induced* / Q000150:complications; D007822:Laryngeal Neoplasms / Q000188:drug therapy; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D007970:Leukopenia / Q000139:chemically induced; D008175:Lung Neoplasms / Q000188:drug therapy; D008297:Male; D009132:Muscles; D009503:Neutropenia / Q000139:chemically induced; D009617:Nocardia Infections / Q000188:drug therapy / Q000635:transmission*; D009616:Nocardia asteroides / Q000302:isolation & purification; D010146:Pain; D012141:Respiratory Tract Infections / Q000188:drug therapy / Q000635:transmission*; D013183:Sputum / Q000382:microbiology; D013307:Streptomycin / Q000627:therapeutic use; D013411:Sulfadiazine / Q000627:therapeutic use; D013444:Sulfisoxazole / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use
D000970:Antineoplastic Agents; D013449:Sulfonamides; D013411:Sulfadiazine; D013444:Sulfisoxazole; D013307:Streptomycin